Oppositional Defiant Disorder | Defiant Teenager | Defiant Kid | ADHD

Back to ADHD News List

Shire Announces Results Of Its Bioequivalence Study Of SPD465 An Investigational Drug For Adults With ADHD

Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in [click link for full article]

Source: http://www.medicalnewstoday.com/sections/adhd/

 

In schools, treatment plans are often poorly integrated. In addition, there are few special education funds directed specifically for ADHD
 

This page is about Attention deficit hyperactivity disorder (ADHD)

Oppositional Defiant Disorder | Defiant Teenager | Defiant Kid | ADHD